Across TCGA pan-cancer cohorts, RNA5SP175 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RNA5SP175 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNA5SP175 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP175 expression acts as an unfavorable survival marker.

LIHC, KIRC, and OV are the cancer types where RNA5SP175 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.184	0.726	<.001	105	view →
KIRC	DFS	Tertile	All	0.183	0.640	<.001	78	view →
OV	DFS	Tertile	All	0.381	0.548	.016	66	view →
DLBC	DFS	Tertile	II,III,IV	0.097	0.834	<.001	54	view →
STAD	OS	Tertile	II,III,IV	0.452	0.725	<.001	45	view →
PCPG	DFS	Tertile	All	0.720	0.917	.001	42	view →
BLCA	DFS	Tertile	All	0.500	0.636	.012	39	view →
KIRP	DFS	Tertile	IV	0.100	0.537	<.001	36	view →
LUAD	OS	Tertile	III,IV	0.372	0.696	.013	18	view →
ESCA	DFS	Quartile	II,III,IV	0.300	0.543	<.001	18	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
HNSC	OS	Tertile	III,IV	0.261	0.567	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

Exploration

Same gene, other analysis: RNA5SP175 tumor-vs-normal RNA expression · all RNA5SP175 data types